Paul Matthias Diderichsen Selected Research

Crohn Disease (Crohn's Disease)

8/2015

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Matthias Diderichsen Research Topics

Disease

3	Neoplasms (Cancer) 01/2023 - 01/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2013 - 06/2013
1	Squamous Cell Carcinoma of Head and Neck 09/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Body Weight (Weight, Body) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Crohn Disease (Crohn's Disease) 08/2015
1	Rheumatoid Arthritis 08/2015
1	Asthma (Bronchial Asthma) 06/2013

Drug/Important Bio-Agent (IBA)

2	simurosertibIBA 01/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2022
2	N- ((4'- hydroxybiphenyl- 3- yl)methyl)- 2- (3- (2- ((- 2- hydroxy- 2- (4- hydroxy- 3- ((methylsulfonyl)amino)phenyl)ethyl)amino)- 2- methylpropyl)phenyl)acetamideIBA 11/2013 - 06/2013
1	Inhibitor of Apoptosis ProteinsIBA 09/2023
1	Cisplatin (Platino)FDA LinkGeneric 09/2023
1	fms-Like Tyrosine Kinase 3IBA 01/2023
1	Syk KinaseIBA 01/2023
1	CreatinineIBA 01/2022
1	GLPG1690IBA 01/2019
1	lysophosphatidic acidIBA 01/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2019
1	Janus Kinase 1IBA 08/2015
1	GLPG0634IBA 08/2015
1	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2013

Therapy/Procedure

1	Radiotherapy 09/2023
1	Chemoradiotherapy 09/2023
1	Oral Administration 01/2022